483,000
Number of women with HER2+ Breast Cancer
in the United States and European Union[4]
THERANOSTIC SPOTLIGHT
A combined therapeutic and diagnostic approach
for breast cancer
By integrating imaging and targeted radiotherapy, we are pioneering a personalized approach to the management of each patient's condition using a novel method called theranostics.
AIP is on the frontier of molecular drug development.
95%
of rare diseases have not one single
FDA approved drug treatment[3]
DIAGNOSTIC SPOTLIGHT
First-in-kind diagnostics
exclusively for children struggling with a rare pediatric disease
We're focused on children and their families first. We understand that each family enduring a rare pediatric disease faces difficulties from diagnosis to treatment. Using novel modalities to diagnose rare
diseases, we're working to ensure that children suffer less.
1.1 million
Oncology, Neurology, and Rare Pediatric Patients whose quality of life will benefit from solutions
delivered by our pipeline
OUR PIPELINE
Developing tomorrow's breakthroughs
Our experts are accelerating the development pipeline of radiotherapies and PET imaging agents in oncology, neurology, and rare pediatric diseases.
2,200,000
People live with Parkinson's Disease
in the United States and European Union[5]
